Apyx Medical (NASDAQ:APYX) Trading 6.8% Higher

Share on StockTwits

Apyx Medical Corp (NASDAQ:APYX)’s stock price traded up 6.8% during mid-day trading on Tuesday . The company traded as high as $3.58 and last traded at $3.46, 198,110 shares traded hands during mid-day trading. An increase of 111% from the average session volume of 93,700 shares. The stock had previously closed at $3.24.

A number of research analysts recently issued reports on the stock. ValuEngine raised shares of Apyx Medical from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, March 3rd. Zacks Investment Research cut shares of Apyx Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. BidaskClub raised shares of Apyx Medical from a “sell” rating to a “hold” rating in a research note on Wednesday, February 12th. Finally, Piper Sandler decreased their price objective on shares of Apyx Medical from to in a research note on Tuesday, March 17th. Two equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Apyx Medical presently has a consensus rating of “Buy” and a consensus price target of $8.55.

The business’s 50 day simple moving average is $6.26 and its two-hundred day simple moving average is $7.14. The stock has a market cap of $110.71 million, a P/E ratio of -6.55 and a beta of 0.46. The company has a quick ratio of 7.93, a current ratio of 8.73 and a debt-to-equity ratio of 0.01.

Apyx Medical (NASDAQ:APYX) last posted its earnings results on Monday, March 16th. The company reported ($0.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.03. The firm had revenue of $8.38 million for the quarter. Apyx Medical had a negative net margin of 66.19% and a negative return on equity of 23.33%. As a group, research analysts forecast that Apyx Medical Corp will post -1 earnings per share for the current fiscal year.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Cowen AND Company LLC bought a new stake in shares of Apyx Medical in the fourth quarter worth $1,996,000. Goldman Sachs Group Inc. grew its stake in shares of Apyx Medical by 1,148.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 212,439 shares of the company’s stock worth $1,797,000 after purchasing an additional 195,417 shares during the last quarter. Lighthouse Financial Advisors Inc. bought a new stake in shares of Apyx Medical in the fourth quarter worth $1,465,000. State Street Corp grew its stake in shares of Apyx Medical by 34.2% in the third quarter. State Street Corp now owns 557,677 shares of the company’s stock worth $3,775,000 after purchasing an additional 142,098 shares during the last quarter. Finally, Calamos Advisors LLC bought a new stake in shares of Apyx Medical in the fourth quarter worth $1,164,000. 53.45% of the stock is currently owned by hedge funds and other institutional investors.

About Apyx Medical (NASDAQ:APYX)

Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue.

Featured Story: How interest rates affect municipal bond prices

Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Credit Suisse AG Sells 6,113 Shares of Redfin Corp
Credit Suisse AG Sells 6,113 Shares of Redfin Corp
Bank of New York Mellon Corp Sells 32,688 Shares of J & J Snack Foods Corp
Bank of New York Mellon Corp Sells 32,688 Shares of J & J Snack Foods Corp
Ambarella Inc  Shares Purchased by Cubist Systematic Strategies LLC
Ambarella Inc Shares Purchased by Cubist Systematic Strategies LLC
PennyMac Mortgage Investment Trust  Shares Gap Down to $9.88
PennyMac Mortgage Investment Trust Shares Gap Down to $9.88
Engrave Wealth Partners LLC Buys New Position in Vulcan Materials
Engrave Wealth Partners LLC Buys New Position in Vulcan Materials
Engrave Wealth Partners LLC Invests $26,000 in U.S. Bancorp
Engrave Wealth Partners LLC Invests $26,000 in U.S. Bancorp


© 2006-2020 Ticker Report